PHYTOMEDICINE 润色咨询

PHYTOMEDICINE

出版年份:1994 年文章数:2603 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2176492, encodeId=18b221e64926e, content=歇菜了,分配到国人编辑了,看看这几天是不是就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Fri Dec 22 10:48:09 CST 2023, time=2023-12-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1198237, encodeId=3db6119823e3f, content=偏重的研究方向:中药单体<br>经验分享:咨询各位老师,reviewer invited一般多久?目前已经一个月了,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7dd357230, createdName=kkrrkf, createdTime=Tue Mar 01 04:07:35 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114786, encodeId=28612114e8660, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经病学<br>经验分享:我也终于能来分享投稿过程了~在返修的过程中多次参考梅斯医学(Medsci)论坛内的相关经验,从中获益良多,深表感谢。那时候就想着,如果能发表,我就来写写自己的经历。<br>我这篇是review,可能和article不太一样。<br>2022.8.15 submit<br>2022.8.21 修改格式,当天修回。phytomedicine的编辑非常负责任,我投的时候老打不开guide for authors页面,本来这家期刊质量也很高,我又是第一次投sci,我以为肯定会被拒就索性直接提交,没想到编辑还给了一次修改格式的机会。<br>2022.9.25 major revise 编辑和三位审稿人提了很多意见,包括文章组织形式的大改,补充毒理学依据,补充文献可靠性评估等,期限20天。看到这些意见我觉得如果我是编辑,我会拒掉这篇文章(笑)。其中最大的修改是该期刊要求系统综述,但我投了篇传统综述,我真的在怀疑编辑为啥不直接拒掉我。修改的过程比较煎熬,整个国庆假期都在改。找了润色,非常感谢我导师。<br>2022.10.14 revise submit 因为觉得很可能会被拒而忐忑不安长达一个多月。<br>2022.11.19 minor revise 只有一位审稿人提了几点文字上的意见,期限15天,很快修改完成。<br>2022.11.24 revise submit 这次没有那么忐忑不安了。<br>2022.12.12 accept 感谢编辑和审稿人,一块石头算是落地。<br>2022.12.15 proof 以及Elsevier发邮件要求补充图注,并说明非OA发表。<br>2022.12.24 proof完成返回。<br>2023.1.9 publication <br>我算是很幸运的,第一次投sci比较顺利。但也存在一些波折,返修过程中我数度觉得会被拒稿,但很感谢编辑没有因格式和语言而拒绝我,感谢审稿人严格而公正的审阅,通过他们的意见,我才认识到我的初稿是多么的粗糙和漏洞百出;汲取他们的意见后,我才真正学会了怎么去组织一篇review。更是非常感谢我的导师,是他帮我推荐了这家期刊,他真是料事如神;看到编辑和审稿人都要求编辑语言,他直接问我要不要润色,防止了我的稿件再度给编辑和审稿人造成精神污染。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a938439116, createdName=ms8000000831428565, createdTime=Wed Feb 15 19:36:58 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1215883, encodeId=14be1215883d3, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体<br>经验分享:<br>2021.12.13 submit<br>2021.12.17 返回修改格式并提交<br>2021.12.22 分配稿件编号,当天under editor assessment<br>2022.02.07 under review<br>2022.02.13 under review<br>2022.03.01 required reviews completed<br>2022.03.02 revise<br>2022.03.26 返回<br>2022.03.28 under editor assessment<br>2022.04.09 reviewer invited<br>2022.04.11 under review<br>2022.04.13 required reviews completed<br>2022.04.14 required reviews completed<br>2022.04.17 accept<br>2022.04.20 proof<br>2022.04.27 出版<br>首先,非常感谢主编、编辑以及外审人~外审,包括编辑在内共3个审稿人,比较注重创新性及原始数据,补了2个小实验,提交了原始数据。杂志水平非常棒,但是审稿周期长,临近毕业真的要慎重考虑。像我等着文章毕业这种,每天快把phytomedicine的网站及梅斯的讨论区盘烂了。这四个月受尽煎熬,好在终于赶上了毕业。<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6ed5581473, createdName=奶思小仙猪, createdTime=Sat Apr 30 21:34:16 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152921, encodeId=5d56215292109, content=有人知道返修under review后又再次under editor assessment是咋回事吗?之前初审的时候review后没有这个过程。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a428573121, createdName=ms7000001625661097, createdTime=Tue Aug 15 20:00:03 CST 2023, time=2023-08-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:<br>* 11.08 submit<br>* 11.11 改格式<br>* 11.14 under editor assessment <br>* 11.15 reviewer invited + under review <br>* 12.15 revise<br>* 12.31 revise submit + with editor <br>* 01.01 under editor assessment <br>* 01.03 under review<br>* 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=853894, encodeId=7268853894f0, content=审稿速度:4.0<br>经验分享:请问这个杂志有decision in process状态吗?我的被主编和另外一个编辑审核后,就出现了这个状态decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Sun Sep 22 10:33:39 CST 2019, time=2019-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118688, encodeId=13a5211868828, content=请问大家有没有经历过返修后出现reviewer invited的情况<br>具体过程是这样:revise submitted——editor assessment——under review——reviewer invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqyvAhYhYtvZhPQbv6W9bG48UBWtJy8AMPzibXsicSDCgv1uOJypkcnCIOviczsich5xggWr8exjPcTGA/132, createdBy=f5012466353, createdName=Luleihao, createdTime=Fri Mar 10 15:56:10 CST 2023, time=2023-03-10, status=1, ipAttribution=广东省)]
    2023-12-22 P拾荒者 来自浙江省

    歇菜了,分配到国人编辑了,看看这几天是不是就被拒了

    39

    展开39条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2176492, encodeId=18b221e64926e, content=歇菜了,分配到国人编辑了,看看这几天是不是就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Fri Dec 22 10:48:09 CST 2023, time=2023-12-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1198237, encodeId=3db6119823e3f, content=偏重的研究方向:中药单体<br>经验分享:咨询各位老师,reviewer invited一般多久?目前已经一个月了,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7dd357230, createdName=kkrrkf, createdTime=Tue Mar 01 04:07:35 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114786, encodeId=28612114e8660, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经病学<br>经验分享:我也终于能来分享投稿过程了~在返修的过程中多次参考梅斯医学(Medsci)论坛内的相关经验,从中获益良多,深表感谢。那时候就想着,如果能发表,我就来写写自己的经历。<br>我这篇是review,可能和article不太一样。<br>2022.8.15 submit<br>2022.8.21 修改格式,当天修回。phytomedicine的编辑非常负责任,我投的时候老打不开guide for authors页面,本来这家期刊质量也很高,我又是第一次投sci,我以为肯定会被拒就索性直接提交,没想到编辑还给了一次修改格式的机会。<br>2022.9.25 major revise 编辑和三位审稿人提了很多意见,包括文章组织形式的大改,补充毒理学依据,补充文献可靠性评估等,期限20天。看到这些意见我觉得如果我是编辑,我会拒掉这篇文章(笑)。其中最大的修改是该期刊要求系统综述,但我投了篇传统综述,我真的在怀疑编辑为啥不直接拒掉我。修改的过程比较煎熬,整个国庆假期都在改。找了润色,非常感谢我导师。<br>2022.10.14 revise submit 因为觉得很可能会被拒而忐忑不安长达一个多月。<br>2022.11.19 minor revise 只有一位审稿人提了几点文字上的意见,期限15天,很快修改完成。<br>2022.11.24 revise submit 这次没有那么忐忑不安了。<br>2022.12.12 accept 感谢编辑和审稿人,一块石头算是落地。<br>2022.12.15 proof 以及Elsevier发邮件要求补充图注,并说明非OA发表。<br>2022.12.24 proof完成返回。<br>2023.1.9 publication <br>我算是很幸运的,第一次投sci比较顺利。但也存在一些波折,返修过程中我数度觉得会被拒稿,但很感谢编辑没有因格式和语言而拒绝我,感谢审稿人严格而公正的审阅,通过他们的意见,我才认识到我的初稿是多么的粗糙和漏洞百出;汲取他们的意见后,我才真正学会了怎么去组织一篇review。更是非常感谢我的导师,是他帮我推荐了这家期刊,他真是料事如神;看到编辑和审稿人都要求编辑语言,他直接问我要不要润色,防止了我的稿件再度给编辑和审稿人造成精神污染。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a938439116, createdName=ms8000000831428565, createdTime=Wed Feb 15 19:36:58 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1215883, encodeId=14be1215883d3, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体<br>经验分享:<br>2021.12.13 submit<br>2021.12.17 返回修改格式并提交<br>2021.12.22 分配稿件编号,当天under editor assessment<br>2022.02.07 under review<br>2022.02.13 under review<br>2022.03.01 required reviews completed<br>2022.03.02 revise<br>2022.03.26 返回<br>2022.03.28 under editor assessment<br>2022.04.09 reviewer invited<br>2022.04.11 under review<br>2022.04.13 required reviews completed<br>2022.04.14 required reviews completed<br>2022.04.17 accept<br>2022.04.20 proof<br>2022.04.27 出版<br>首先,非常感谢主编、编辑以及外审人~外审,包括编辑在内共3个审稿人,比较注重创新性及原始数据,补了2个小实验,提交了原始数据。杂志水平非常棒,但是审稿周期长,临近毕业真的要慎重考虑。像我等着文章毕业这种,每天快把phytomedicine的网站及梅斯的讨论区盘烂了。这四个月受尽煎熬,好在终于赶上了毕业。<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6ed5581473, createdName=奶思小仙猪, createdTime=Sat Apr 30 21:34:16 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152921, encodeId=5d56215292109, content=有人知道返修under review后又再次under editor assessment是咋回事吗?之前初审的时候review后没有这个过程。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a428573121, createdName=ms7000001625661097, createdTime=Tue Aug 15 20:00:03 CST 2023, time=2023-08-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:<br>* 11.08 submit<br>* 11.11 改格式<br>* 11.14 under editor assessment <br>* 11.15 reviewer invited + under review <br>* 12.15 revise<br>* 12.31 revise submit + with editor <br>* 01.01 under editor assessment <br>* 01.03 under review<br>* 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=853894, encodeId=7268853894f0, content=审稿速度:4.0<br>经验分享:请问这个杂志有decision in process状态吗?我的被主编和另外一个编辑审核后,就出现了这个状态decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Sun Sep 22 10:33:39 CST 2019, time=2019-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118688, encodeId=13a5211868828, content=请问大家有没有经历过返修后出现reviewer invited的情况<br>具体过程是这样:revise submitted——editor assessment——under review——reviewer invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqyvAhYhYtvZhPQbv6W9bG48UBWtJy8AMPzibXsicSDCgv1uOJypkcnCIOviczsich5xggWr8exjPcTGA/132, createdBy=f5012466353, createdName=Luleihao, createdTime=Fri Mar 10 15:56:10 CST 2023, time=2023-03-10, status=1, ipAttribution=广东省)]
    2023-12-28 samtol 来自浙江省

    让我修了两轮的格式和图片
    12.25 submitted to journal
    12.26 under editor assessment

    26

    展开26条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2176492, encodeId=18b221e64926e, content=歇菜了,分配到国人编辑了,看看这几天是不是就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Fri Dec 22 10:48:09 CST 2023, time=2023-12-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1198237, encodeId=3db6119823e3f, content=偏重的研究方向:中药单体<br>经验分享:咨询各位老师,reviewer invited一般多久?目前已经一个月了,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7dd357230, createdName=kkrrkf, createdTime=Tue Mar 01 04:07:35 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114786, encodeId=28612114e8660, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经病学<br>经验分享:我也终于能来分享投稿过程了~在返修的过程中多次参考梅斯医学(Medsci)论坛内的相关经验,从中获益良多,深表感谢。那时候就想着,如果能发表,我就来写写自己的经历。<br>我这篇是review,可能和article不太一样。<br>2022.8.15 submit<br>2022.8.21 修改格式,当天修回。phytomedicine的编辑非常负责任,我投的时候老打不开guide for authors页面,本来这家期刊质量也很高,我又是第一次投sci,我以为肯定会被拒就索性直接提交,没想到编辑还给了一次修改格式的机会。<br>2022.9.25 major revise 编辑和三位审稿人提了很多意见,包括文章组织形式的大改,补充毒理学依据,补充文献可靠性评估等,期限20天。看到这些意见我觉得如果我是编辑,我会拒掉这篇文章(笑)。其中最大的修改是该期刊要求系统综述,但我投了篇传统综述,我真的在怀疑编辑为啥不直接拒掉我。修改的过程比较煎熬,整个国庆假期都在改。找了润色,非常感谢我导师。<br>2022.10.14 revise submit 因为觉得很可能会被拒而忐忑不安长达一个多月。<br>2022.11.19 minor revise 只有一位审稿人提了几点文字上的意见,期限15天,很快修改完成。<br>2022.11.24 revise submit 这次没有那么忐忑不安了。<br>2022.12.12 accept 感谢编辑和审稿人,一块石头算是落地。<br>2022.12.15 proof 以及Elsevier发邮件要求补充图注,并说明非OA发表。<br>2022.12.24 proof完成返回。<br>2023.1.9 publication <br>我算是很幸运的,第一次投sci比较顺利。但也存在一些波折,返修过程中我数度觉得会被拒稿,但很感谢编辑没有因格式和语言而拒绝我,感谢审稿人严格而公正的审阅,通过他们的意见,我才认识到我的初稿是多么的粗糙和漏洞百出;汲取他们的意见后,我才真正学会了怎么去组织一篇review。更是非常感谢我的导师,是他帮我推荐了这家期刊,他真是料事如神;看到编辑和审稿人都要求编辑语言,他直接问我要不要润色,防止了我的稿件再度给编辑和审稿人造成精神污染。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a938439116, createdName=ms8000000831428565, createdTime=Wed Feb 15 19:36:58 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1215883, encodeId=14be1215883d3, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体<br>经验分享:<br>2021.12.13 submit<br>2021.12.17 返回修改格式并提交<br>2021.12.22 分配稿件编号,当天under editor assessment<br>2022.02.07 under review<br>2022.02.13 under review<br>2022.03.01 required reviews completed<br>2022.03.02 revise<br>2022.03.26 返回<br>2022.03.28 under editor assessment<br>2022.04.09 reviewer invited<br>2022.04.11 under review<br>2022.04.13 required reviews completed<br>2022.04.14 required reviews completed<br>2022.04.17 accept<br>2022.04.20 proof<br>2022.04.27 出版<br>首先,非常感谢主编、编辑以及外审人~外审,包括编辑在内共3个审稿人,比较注重创新性及原始数据,补了2个小实验,提交了原始数据。杂志水平非常棒,但是审稿周期长,临近毕业真的要慎重考虑。像我等着文章毕业这种,每天快把phytomedicine的网站及梅斯的讨论区盘烂了。这四个月受尽煎熬,好在终于赶上了毕业。<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6ed5581473, createdName=奶思小仙猪, createdTime=Sat Apr 30 21:34:16 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152921, encodeId=5d56215292109, content=有人知道返修under review后又再次under editor assessment是咋回事吗?之前初审的时候review后没有这个过程。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a428573121, createdName=ms7000001625661097, createdTime=Tue Aug 15 20:00:03 CST 2023, time=2023-08-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:<br>* 11.08 submit<br>* 11.11 改格式<br>* 11.14 under editor assessment <br>* 11.15 reviewer invited + under review <br>* 12.15 revise<br>* 12.31 revise submit + with editor <br>* 01.01 under editor assessment <br>* 01.03 under review<br>* 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=853894, encodeId=7268853894f0, content=审稿速度:4.0<br>经验分享:请问这个杂志有decision in process状态吗?我的被主编和另外一个编辑审核后,就出现了这个状态decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Sun Sep 22 10:33:39 CST 2019, time=2019-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118688, encodeId=13a5211868828, content=请问大家有没有经历过返修后出现reviewer invited的情况<br>具体过程是这样:revise submitted——editor assessment——under review——reviewer invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqyvAhYhYtvZhPQbv6W9bG48UBWtJy8AMPzibXsicSDCgv1uOJypkcnCIOviczsich5xggWr8exjPcTGA/132, createdBy=f5012466353, createdName=Luleihao, createdTime=Fri Mar 10 15:56:10 CST 2023, time=2023-03-10, status=1, ipAttribution=广东省)]
    2022-03-01 kkrrkf

    偏重的研究方向:中药单体
    经验分享:咨询各位老师,reviewer invited一般多久?目前已经一个月了,谢谢

    25

    展开25条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2176492, encodeId=18b221e64926e, content=歇菜了,分配到国人编辑了,看看这几天是不是就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Fri Dec 22 10:48:09 CST 2023, time=2023-12-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1198237, encodeId=3db6119823e3f, content=偏重的研究方向:中药单体<br>经验分享:咨询各位老师,reviewer invited一般多久?目前已经一个月了,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7dd357230, createdName=kkrrkf, createdTime=Tue Mar 01 04:07:35 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114786, encodeId=28612114e8660, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经病学<br>经验分享:我也终于能来分享投稿过程了~在返修的过程中多次参考梅斯医学(Medsci)论坛内的相关经验,从中获益良多,深表感谢。那时候就想着,如果能发表,我就来写写自己的经历。<br>我这篇是review,可能和article不太一样。<br>2022.8.15 submit<br>2022.8.21 修改格式,当天修回。phytomedicine的编辑非常负责任,我投的时候老打不开guide for authors页面,本来这家期刊质量也很高,我又是第一次投sci,我以为肯定会被拒就索性直接提交,没想到编辑还给了一次修改格式的机会。<br>2022.9.25 major revise 编辑和三位审稿人提了很多意见,包括文章组织形式的大改,补充毒理学依据,补充文献可靠性评估等,期限20天。看到这些意见我觉得如果我是编辑,我会拒掉这篇文章(笑)。其中最大的修改是该期刊要求系统综述,但我投了篇传统综述,我真的在怀疑编辑为啥不直接拒掉我。修改的过程比较煎熬,整个国庆假期都在改。找了润色,非常感谢我导师。<br>2022.10.14 revise submit 因为觉得很可能会被拒而忐忑不安长达一个多月。<br>2022.11.19 minor revise 只有一位审稿人提了几点文字上的意见,期限15天,很快修改完成。<br>2022.11.24 revise submit 这次没有那么忐忑不安了。<br>2022.12.12 accept 感谢编辑和审稿人,一块石头算是落地。<br>2022.12.15 proof 以及Elsevier发邮件要求补充图注,并说明非OA发表。<br>2022.12.24 proof完成返回。<br>2023.1.9 publication <br>我算是很幸运的,第一次投sci比较顺利。但也存在一些波折,返修过程中我数度觉得会被拒稿,但很感谢编辑没有因格式和语言而拒绝我,感谢审稿人严格而公正的审阅,通过他们的意见,我才认识到我的初稿是多么的粗糙和漏洞百出;汲取他们的意见后,我才真正学会了怎么去组织一篇review。更是非常感谢我的导师,是他帮我推荐了这家期刊,他真是料事如神;看到编辑和审稿人都要求编辑语言,他直接问我要不要润色,防止了我的稿件再度给编辑和审稿人造成精神污染。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a938439116, createdName=ms8000000831428565, createdTime=Wed Feb 15 19:36:58 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1215883, encodeId=14be1215883d3, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体<br>经验分享:<br>2021.12.13 submit<br>2021.12.17 返回修改格式并提交<br>2021.12.22 分配稿件编号,当天under editor assessment<br>2022.02.07 under review<br>2022.02.13 under review<br>2022.03.01 required reviews completed<br>2022.03.02 revise<br>2022.03.26 返回<br>2022.03.28 under editor assessment<br>2022.04.09 reviewer invited<br>2022.04.11 under review<br>2022.04.13 required reviews completed<br>2022.04.14 required reviews completed<br>2022.04.17 accept<br>2022.04.20 proof<br>2022.04.27 出版<br>首先,非常感谢主编、编辑以及外审人~外审,包括编辑在内共3个审稿人,比较注重创新性及原始数据,补了2个小实验,提交了原始数据。杂志水平非常棒,但是审稿周期长,临近毕业真的要慎重考虑。像我等着文章毕业这种,每天快把phytomedicine的网站及梅斯的讨论区盘烂了。这四个月受尽煎熬,好在终于赶上了毕业。<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6ed5581473, createdName=奶思小仙猪, createdTime=Sat Apr 30 21:34:16 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152921, encodeId=5d56215292109, content=有人知道返修under review后又再次under editor assessment是咋回事吗?之前初审的时候review后没有这个过程。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a428573121, createdName=ms7000001625661097, createdTime=Tue Aug 15 20:00:03 CST 2023, time=2023-08-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:<br>* 11.08 submit<br>* 11.11 改格式<br>* 11.14 under editor assessment <br>* 11.15 reviewer invited + under review <br>* 12.15 revise<br>* 12.31 revise submit + with editor <br>* 01.01 under editor assessment <br>* 01.03 under review<br>* 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=853894, encodeId=7268853894f0, content=审稿速度:4.0<br>经验分享:请问这个杂志有decision in process状态吗?我的被主编和另外一个编辑审核后,就出现了这个状态decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Sun Sep 22 10:33:39 CST 2019, time=2019-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118688, encodeId=13a5211868828, content=请问大家有没有经历过返修后出现reviewer invited的情况<br>具体过程是这样:revise submitted——editor assessment——under review——reviewer invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqyvAhYhYtvZhPQbv6W9bG48UBWtJy8AMPzibXsicSDCgv1uOJypkcnCIOviczsich5xggWr8exjPcTGA/132, createdBy=f5012466353, createdName=Luleihao, createdTime=Fri Mar 10 15:56:10 CST 2023, time=2023-03-10, status=1, ipAttribution=广东省)]
    2023-02-15 ms8000000831428565 来自山东省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:神经病学
    经验分享:我也终于能来分享投稿过程了~在返修的过程中多次参考梅斯医学(Medsci)论坛内的相关经验,从中获益良多,深表感谢。那时候就想着,如果能发表,我就来写写自己的经历。
    我这篇是review,可能和article不太一样。
    2022.8.15 submit
    2022.8.21 修改格式,当天修回。phytomedicine的编辑非常负责任,我投的时候老打不开guide for authors页面,本来这家期刊质量也很高,我又是第一次投sci,我以为肯定会被拒就索性直接提交,没想到编辑还给了一次修改格式的机会。
    2022.9.25 major revise 编辑和三位审稿人提了很多意见,包括文章组织形式的大改,补充毒理学依据,补充文献可靠性评估等,期限20天。看到这些意见我觉得如果我是编辑,我会拒掉这篇文章(笑)。其中最大的修改是该期刊要求系统综述,但我投了篇传统综述,我真的在怀疑编辑为啥不直接拒掉我。修改的过程比较煎熬,整个国庆假期都在改。找了润色,非常感谢我导师。
    2022.10.14 revise submit 因为觉得很可能会被拒而忐忑不安长达一个多月。
    2022.11.19 minor revise 只有一位审稿人提了几点文字上的意见,期限15天,很快修改完成。
    2022.11.24 revise submit 这次没有那么忐忑不安了。
    2022.12.12 accept 感谢编辑和审稿人,一块石头算是落地。
    2022.12.15 proof 以及Elsevier发邮件要求补充图注,并说明非OA发表。
    2022.12.24 proof完成返回。
    2023.1.9 publication
    我算是很幸运的,第一次投sci比较顺利。但也存在一些波折,返修过程中我数度觉得会被拒稿,但很感谢编辑没有因格式和语言而拒绝我,感谢审稿人严格而公正的审阅,通过他们的意见,我才认识到我的初稿是多么的粗糙和漏洞百出;汲取他们的意见后,我才真正学会了怎么去组织一篇review。更是非常感谢我的导师,是他帮我推荐了这家期刊,他真是料事如神;看到编辑和审稿人都要求编辑语言,他直接问我要不要润色,防止了我的稿件再度给编辑和审稿人造成精神污染。

    25

    展开25条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2176492, encodeId=18b221e64926e, content=歇菜了,分配到国人编辑了,看看这几天是不是就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Fri Dec 22 10:48:09 CST 2023, time=2023-12-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1198237, encodeId=3db6119823e3f, content=偏重的研究方向:中药单体<br>经验分享:咨询各位老师,reviewer invited一般多久?目前已经一个月了,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7dd357230, createdName=kkrrkf, createdTime=Tue Mar 01 04:07:35 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114786, encodeId=28612114e8660, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经病学<br>经验分享:我也终于能来分享投稿过程了~在返修的过程中多次参考梅斯医学(Medsci)论坛内的相关经验,从中获益良多,深表感谢。那时候就想着,如果能发表,我就来写写自己的经历。<br>我这篇是review,可能和article不太一样。<br>2022.8.15 submit<br>2022.8.21 修改格式,当天修回。phytomedicine的编辑非常负责任,我投的时候老打不开guide for authors页面,本来这家期刊质量也很高,我又是第一次投sci,我以为肯定会被拒就索性直接提交,没想到编辑还给了一次修改格式的机会。<br>2022.9.25 major revise 编辑和三位审稿人提了很多意见,包括文章组织形式的大改,补充毒理学依据,补充文献可靠性评估等,期限20天。看到这些意见我觉得如果我是编辑,我会拒掉这篇文章(笑)。其中最大的修改是该期刊要求系统综述,但我投了篇传统综述,我真的在怀疑编辑为啥不直接拒掉我。修改的过程比较煎熬,整个国庆假期都在改。找了润色,非常感谢我导师。<br>2022.10.14 revise submit 因为觉得很可能会被拒而忐忑不安长达一个多月。<br>2022.11.19 minor revise 只有一位审稿人提了几点文字上的意见,期限15天,很快修改完成。<br>2022.11.24 revise submit 这次没有那么忐忑不安了。<br>2022.12.12 accept 感谢编辑和审稿人,一块石头算是落地。<br>2022.12.15 proof 以及Elsevier发邮件要求补充图注,并说明非OA发表。<br>2022.12.24 proof完成返回。<br>2023.1.9 publication <br>我算是很幸运的,第一次投sci比较顺利。但也存在一些波折,返修过程中我数度觉得会被拒稿,但很感谢编辑没有因格式和语言而拒绝我,感谢审稿人严格而公正的审阅,通过他们的意见,我才认识到我的初稿是多么的粗糙和漏洞百出;汲取他们的意见后,我才真正学会了怎么去组织一篇review。更是非常感谢我的导师,是他帮我推荐了这家期刊,他真是料事如神;看到编辑和审稿人都要求编辑语言,他直接问我要不要润色,防止了我的稿件再度给编辑和审稿人造成精神污染。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a938439116, createdName=ms8000000831428565, createdTime=Wed Feb 15 19:36:58 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1215883, encodeId=14be1215883d3, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体<br>经验分享:<br>2021.12.13 submit<br>2021.12.17 返回修改格式并提交<br>2021.12.22 分配稿件编号,当天under editor assessment<br>2022.02.07 under review<br>2022.02.13 under review<br>2022.03.01 required reviews completed<br>2022.03.02 revise<br>2022.03.26 返回<br>2022.03.28 under editor assessment<br>2022.04.09 reviewer invited<br>2022.04.11 under review<br>2022.04.13 required reviews completed<br>2022.04.14 required reviews completed<br>2022.04.17 accept<br>2022.04.20 proof<br>2022.04.27 出版<br>首先,非常感谢主编、编辑以及外审人~外审,包括编辑在内共3个审稿人,比较注重创新性及原始数据,补了2个小实验,提交了原始数据。杂志水平非常棒,但是审稿周期长,临近毕业真的要慎重考虑。像我等着文章毕业这种,每天快把phytomedicine的网站及梅斯的讨论区盘烂了。这四个月受尽煎熬,好在终于赶上了毕业。<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6ed5581473, createdName=奶思小仙猪, createdTime=Sat Apr 30 21:34:16 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152921, encodeId=5d56215292109, content=有人知道返修under review后又再次under editor assessment是咋回事吗?之前初审的时候review后没有这个过程。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a428573121, createdName=ms7000001625661097, createdTime=Tue Aug 15 20:00:03 CST 2023, time=2023-08-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:<br>* 11.08 submit<br>* 11.11 改格式<br>* 11.14 under editor assessment <br>* 11.15 reviewer invited + under review <br>* 12.15 revise<br>* 12.31 revise submit + with editor <br>* 01.01 under editor assessment <br>* 01.03 under review<br>* 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=853894, encodeId=7268853894f0, content=审稿速度:4.0<br>经验分享:请问这个杂志有decision in process状态吗?我的被主编和另外一个编辑审核后,就出现了这个状态decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Sun Sep 22 10:33:39 CST 2019, time=2019-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118688, encodeId=13a5211868828, content=请问大家有没有经历过返修后出现reviewer invited的情况<br>具体过程是这样:revise submitted——editor assessment——under review——reviewer invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqyvAhYhYtvZhPQbv6W9bG48UBWtJy8AMPzibXsicSDCgv1uOJypkcnCIOviczsich5xggWr8exjPcTGA/132, createdBy=f5012466353, createdName=Luleihao, createdTime=Fri Mar 10 15:56:10 CST 2023, time=2023-03-10, status=1, ipAttribution=广东省)]
    2022-04-30 奶思小仙猪

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:中药单体
    经验分享:
    2021.12.13 submit
    2021.12.17 返回修改格式并提交
    2021.12.22 分配稿件编号,当天under editor assessment
    2022.02.07 under review
    2022.02.13 under review
    2022.03.01 required reviews completed
    2022.03.02 revise
    2022.03.26 返回
    2022.03.28 under editor assessment
    2022.04.09 reviewer invited
    2022.04.11 under review
    2022.04.13 required reviews completed
    2022.04.14 required reviews completed
    2022.04.17 accept
    2022.04.20 proof
    2022.04.27 出版
    首先,非常感谢主编、编辑以及外审人~外审,包括编辑在内共3个审稿人,比较注重创新性及原始数据,补了2个小实验,提交了原始数据。杂志水平非常棒,但是审稿周期长,临近毕业真的要慎重考虑。像我等着文章毕业这种,每天快把phytomedicine的网站及梅斯的讨论区盘烂了。这四个月受尽煎熬,好在终于赶上了毕业。


    25

    展开25条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2176492, encodeId=18b221e64926e, content=歇菜了,分配到国人编辑了,看看这几天是不是就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Fri Dec 22 10:48:09 CST 2023, time=2023-12-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1198237, encodeId=3db6119823e3f, content=偏重的研究方向:中药单体<br>经验分享:咨询各位老师,reviewer invited一般多久?目前已经一个月了,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7dd357230, createdName=kkrrkf, createdTime=Tue Mar 01 04:07:35 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114786, encodeId=28612114e8660, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经病学<br>经验分享:我也终于能来分享投稿过程了~在返修的过程中多次参考梅斯医学(Medsci)论坛内的相关经验,从中获益良多,深表感谢。那时候就想着,如果能发表,我就来写写自己的经历。<br>我这篇是review,可能和article不太一样。<br>2022.8.15 submit<br>2022.8.21 修改格式,当天修回。phytomedicine的编辑非常负责任,我投的时候老打不开guide for authors页面,本来这家期刊质量也很高,我又是第一次投sci,我以为肯定会被拒就索性直接提交,没想到编辑还给了一次修改格式的机会。<br>2022.9.25 major revise 编辑和三位审稿人提了很多意见,包括文章组织形式的大改,补充毒理学依据,补充文献可靠性评估等,期限20天。看到这些意见我觉得如果我是编辑,我会拒掉这篇文章(笑)。其中最大的修改是该期刊要求系统综述,但我投了篇传统综述,我真的在怀疑编辑为啥不直接拒掉我。修改的过程比较煎熬,整个国庆假期都在改。找了润色,非常感谢我导师。<br>2022.10.14 revise submit 因为觉得很可能会被拒而忐忑不安长达一个多月。<br>2022.11.19 minor revise 只有一位审稿人提了几点文字上的意见,期限15天,很快修改完成。<br>2022.11.24 revise submit 这次没有那么忐忑不安了。<br>2022.12.12 accept 感谢编辑和审稿人,一块石头算是落地。<br>2022.12.15 proof 以及Elsevier发邮件要求补充图注,并说明非OA发表。<br>2022.12.24 proof完成返回。<br>2023.1.9 publication <br>我算是很幸运的,第一次投sci比较顺利。但也存在一些波折,返修过程中我数度觉得会被拒稿,但很感谢编辑没有因格式和语言而拒绝我,感谢审稿人严格而公正的审阅,通过他们的意见,我才认识到我的初稿是多么的粗糙和漏洞百出;汲取他们的意见后,我才真正学会了怎么去组织一篇review。更是非常感谢我的导师,是他帮我推荐了这家期刊,他真是料事如神;看到编辑和审稿人都要求编辑语言,他直接问我要不要润色,防止了我的稿件再度给编辑和审稿人造成精神污染。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a938439116, createdName=ms8000000831428565, createdTime=Wed Feb 15 19:36:58 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1215883, encodeId=14be1215883d3, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体<br>经验分享:<br>2021.12.13 submit<br>2021.12.17 返回修改格式并提交<br>2021.12.22 分配稿件编号,当天under editor assessment<br>2022.02.07 under review<br>2022.02.13 under review<br>2022.03.01 required reviews completed<br>2022.03.02 revise<br>2022.03.26 返回<br>2022.03.28 under editor assessment<br>2022.04.09 reviewer invited<br>2022.04.11 under review<br>2022.04.13 required reviews completed<br>2022.04.14 required reviews completed<br>2022.04.17 accept<br>2022.04.20 proof<br>2022.04.27 出版<br>首先,非常感谢主编、编辑以及外审人~外审,包括编辑在内共3个审稿人,比较注重创新性及原始数据,补了2个小实验,提交了原始数据。杂志水平非常棒,但是审稿周期长,临近毕业真的要慎重考虑。像我等着文章毕业这种,每天快把phytomedicine的网站及梅斯的讨论区盘烂了。这四个月受尽煎熬,好在终于赶上了毕业。<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6ed5581473, createdName=奶思小仙猪, createdTime=Sat Apr 30 21:34:16 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152921, encodeId=5d56215292109, content=有人知道返修under review后又再次under editor assessment是咋回事吗?之前初审的时候review后没有这个过程。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a428573121, createdName=ms7000001625661097, createdTime=Tue Aug 15 20:00:03 CST 2023, time=2023-08-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:<br>* 11.08 submit<br>* 11.11 改格式<br>* 11.14 under editor assessment <br>* 11.15 reviewer invited + under review <br>* 12.15 revise<br>* 12.31 revise submit + with editor <br>* 01.01 under editor assessment <br>* 01.03 under review<br>* 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=853894, encodeId=7268853894f0, content=审稿速度:4.0<br>经验分享:请问这个杂志有decision in process状态吗?我的被主编和另外一个编辑审核后,就出现了这个状态decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Sun Sep 22 10:33:39 CST 2019, time=2019-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118688, encodeId=13a5211868828, content=请问大家有没有经历过返修后出现reviewer invited的情况<br>具体过程是这样:revise submitted——editor assessment——under review——reviewer invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqyvAhYhYtvZhPQbv6W9bG48UBWtJy8AMPzibXsicSDCgv1uOJypkcnCIOviczsich5xggWr8exjPcTGA/132, createdBy=f5012466353, createdName=Luleihao, createdTime=Fri Mar 10 15:56:10 CST 2023, time=2023-03-10, status=1, ipAttribution=广东省)]
    2023-08-15 ms7000001625661097 来自浙江省

    有人知道返修under review后又再次under editor assessment是咋回事吗?之前初审的时候review后没有这个过程。

    22

    展开22条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2176492, encodeId=18b221e64926e, content=歇菜了,分配到国人编辑了,看看这几天是不是就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Fri Dec 22 10:48:09 CST 2023, time=2023-12-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1198237, encodeId=3db6119823e3f, content=偏重的研究方向:中药单体<br>经验分享:咨询各位老师,reviewer invited一般多久?目前已经一个月了,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7dd357230, createdName=kkrrkf, createdTime=Tue Mar 01 04:07:35 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114786, encodeId=28612114e8660, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经病学<br>经验分享:我也终于能来分享投稿过程了~在返修的过程中多次参考梅斯医学(Medsci)论坛内的相关经验,从中获益良多,深表感谢。那时候就想着,如果能发表,我就来写写自己的经历。<br>我这篇是review,可能和article不太一样。<br>2022.8.15 submit<br>2022.8.21 修改格式,当天修回。phytomedicine的编辑非常负责任,我投的时候老打不开guide for authors页面,本来这家期刊质量也很高,我又是第一次投sci,我以为肯定会被拒就索性直接提交,没想到编辑还给了一次修改格式的机会。<br>2022.9.25 major revise 编辑和三位审稿人提了很多意见,包括文章组织形式的大改,补充毒理学依据,补充文献可靠性评估等,期限20天。看到这些意见我觉得如果我是编辑,我会拒掉这篇文章(笑)。其中最大的修改是该期刊要求系统综述,但我投了篇传统综述,我真的在怀疑编辑为啥不直接拒掉我。修改的过程比较煎熬,整个国庆假期都在改。找了润色,非常感谢我导师。<br>2022.10.14 revise submit 因为觉得很可能会被拒而忐忑不安长达一个多月。<br>2022.11.19 minor revise 只有一位审稿人提了几点文字上的意见,期限15天,很快修改完成。<br>2022.11.24 revise submit 这次没有那么忐忑不安了。<br>2022.12.12 accept 感谢编辑和审稿人,一块石头算是落地。<br>2022.12.15 proof 以及Elsevier发邮件要求补充图注,并说明非OA发表。<br>2022.12.24 proof完成返回。<br>2023.1.9 publication <br>我算是很幸运的,第一次投sci比较顺利。但也存在一些波折,返修过程中我数度觉得会被拒稿,但很感谢编辑没有因格式和语言而拒绝我,感谢审稿人严格而公正的审阅,通过他们的意见,我才认识到我的初稿是多么的粗糙和漏洞百出;汲取他们的意见后,我才真正学会了怎么去组织一篇review。更是非常感谢我的导师,是他帮我推荐了这家期刊,他真是料事如神;看到编辑和审稿人都要求编辑语言,他直接问我要不要润色,防止了我的稿件再度给编辑和审稿人造成精神污染。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a938439116, createdName=ms8000000831428565, createdTime=Wed Feb 15 19:36:58 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1215883, encodeId=14be1215883d3, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体<br>经验分享:<br>2021.12.13 submit<br>2021.12.17 返回修改格式并提交<br>2021.12.22 分配稿件编号,当天under editor assessment<br>2022.02.07 under review<br>2022.02.13 under review<br>2022.03.01 required reviews completed<br>2022.03.02 revise<br>2022.03.26 返回<br>2022.03.28 under editor assessment<br>2022.04.09 reviewer invited<br>2022.04.11 under review<br>2022.04.13 required reviews completed<br>2022.04.14 required reviews completed<br>2022.04.17 accept<br>2022.04.20 proof<br>2022.04.27 出版<br>首先,非常感谢主编、编辑以及外审人~外审,包括编辑在内共3个审稿人,比较注重创新性及原始数据,补了2个小实验,提交了原始数据。杂志水平非常棒,但是审稿周期长,临近毕业真的要慎重考虑。像我等着文章毕业这种,每天快把phytomedicine的网站及梅斯的讨论区盘烂了。这四个月受尽煎熬,好在终于赶上了毕业。<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6ed5581473, createdName=奶思小仙猪, createdTime=Sat Apr 30 21:34:16 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152921, encodeId=5d56215292109, content=有人知道返修under review后又再次under editor assessment是咋回事吗?之前初审的时候review后没有这个过程。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a428573121, createdName=ms7000001625661097, createdTime=Tue Aug 15 20:00:03 CST 2023, time=2023-08-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:<br>* 11.08 submit<br>* 11.11 改格式<br>* 11.14 under editor assessment <br>* 11.15 reviewer invited + under review <br>* 12.15 revise<br>* 12.31 revise submit + with editor <br>* 01.01 under editor assessment <br>* 01.03 under review<br>* 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=853894, encodeId=7268853894f0, content=审稿速度:4.0<br>经验分享:请问这个杂志有decision in process状态吗?我的被主编和另外一个编辑审核后,就出现了这个状态decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Sun Sep 22 10:33:39 CST 2019, time=2019-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118688, encodeId=13a5211868828, content=请问大家有没有经历过返修后出现reviewer invited的情况<br>具体过程是这样:revise submitted——editor assessment——under review——reviewer invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqyvAhYhYtvZhPQbv6W9bG48UBWtJy8AMPzibXsicSDCgv1uOJypkcnCIOviczsich5xggWr8exjPcTGA/132, createdBy=f5012466353, createdName=Luleihao, createdTime=Fri Mar 10 15:56:10 CST 2023, time=2023-03-10, status=1, ipAttribution=广东省)]
    2023-04-18 ms2000000770833142 来自广东省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:中药复方;代谢病
    经验分享:2023.02.25 submit
    2023.03.03 under editor assessment
    2023.03.09 under review
    2023.03.19 required reviews completed
    2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。
    2023.04.12 返回
    2023.04.17 under editor assessment
    2023.04.18 reviewer invited
    目前是这种状态,后续再更新状态。

    希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。
    编辑和杂志都不错,效率其实还行。

    希望能赶在毕业前接收~

    20

    展开20条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2176492, encodeId=18b221e64926e, content=歇菜了,分配到国人编辑了,看看这几天是不是就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Fri Dec 22 10:48:09 CST 2023, time=2023-12-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1198237, encodeId=3db6119823e3f, content=偏重的研究方向:中药单体<br>经验分享:咨询各位老师,reviewer invited一般多久?目前已经一个月了,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7dd357230, createdName=kkrrkf, createdTime=Tue Mar 01 04:07:35 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114786, encodeId=28612114e8660, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经病学<br>经验分享:我也终于能来分享投稿过程了~在返修的过程中多次参考梅斯医学(Medsci)论坛内的相关经验,从中获益良多,深表感谢。那时候就想着,如果能发表,我就来写写自己的经历。<br>我这篇是review,可能和article不太一样。<br>2022.8.15 submit<br>2022.8.21 修改格式,当天修回。phytomedicine的编辑非常负责任,我投的时候老打不开guide for authors页面,本来这家期刊质量也很高,我又是第一次投sci,我以为肯定会被拒就索性直接提交,没想到编辑还给了一次修改格式的机会。<br>2022.9.25 major revise 编辑和三位审稿人提了很多意见,包括文章组织形式的大改,补充毒理学依据,补充文献可靠性评估等,期限20天。看到这些意见我觉得如果我是编辑,我会拒掉这篇文章(笑)。其中最大的修改是该期刊要求系统综述,但我投了篇传统综述,我真的在怀疑编辑为啥不直接拒掉我。修改的过程比较煎熬,整个国庆假期都在改。找了润色,非常感谢我导师。<br>2022.10.14 revise submit 因为觉得很可能会被拒而忐忑不安长达一个多月。<br>2022.11.19 minor revise 只有一位审稿人提了几点文字上的意见,期限15天,很快修改完成。<br>2022.11.24 revise submit 这次没有那么忐忑不安了。<br>2022.12.12 accept 感谢编辑和审稿人,一块石头算是落地。<br>2022.12.15 proof 以及Elsevier发邮件要求补充图注,并说明非OA发表。<br>2022.12.24 proof完成返回。<br>2023.1.9 publication <br>我算是很幸运的,第一次投sci比较顺利。但也存在一些波折,返修过程中我数度觉得会被拒稿,但很感谢编辑没有因格式和语言而拒绝我,感谢审稿人严格而公正的审阅,通过他们的意见,我才认识到我的初稿是多么的粗糙和漏洞百出;汲取他们的意见后,我才真正学会了怎么去组织一篇review。更是非常感谢我的导师,是他帮我推荐了这家期刊,他真是料事如神;看到编辑和审稿人都要求编辑语言,他直接问我要不要润色,防止了我的稿件再度给编辑和审稿人造成精神污染。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a938439116, createdName=ms8000000831428565, createdTime=Wed Feb 15 19:36:58 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1215883, encodeId=14be1215883d3, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体<br>经验分享:<br>2021.12.13 submit<br>2021.12.17 返回修改格式并提交<br>2021.12.22 分配稿件编号,当天under editor assessment<br>2022.02.07 under review<br>2022.02.13 under review<br>2022.03.01 required reviews completed<br>2022.03.02 revise<br>2022.03.26 返回<br>2022.03.28 under editor assessment<br>2022.04.09 reviewer invited<br>2022.04.11 under review<br>2022.04.13 required reviews completed<br>2022.04.14 required reviews completed<br>2022.04.17 accept<br>2022.04.20 proof<br>2022.04.27 出版<br>首先,非常感谢主编、编辑以及外审人~外审,包括编辑在内共3个审稿人,比较注重创新性及原始数据,补了2个小实验,提交了原始数据。杂志水平非常棒,但是审稿周期长,临近毕业真的要慎重考虑。像我等着文章毕业这种,每天快把phytomedicine的网站及梅斯的讨论区盘烂了。这四个月受尽煎熬,好在终于赶上了毕业。<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6ed5581473, createdName=奶思小仙猪, createdTime=Sat Apr 30 21:34:16 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152921, encodeId=5d56215292109, content=有人知道返修under review后又再次under editor assessment是咋回事吗?之前初审的时候review后没有这个过程。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a428573121, createdName=ms7000001625661097, createdTime=Tue Aug 15 20:00:03 CST 2023, time=2023-08-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:<br>* 11.08 submit<br>* 11.11 改格式<br>* 11.14 under editor assessment <br>* 11.15 reviewer invited + under review <br>* 12.15 revise<br>* 12.31 revise submit + with editor <br>* 01.01 under editor assessment <br>* 01.03 under review<br>* 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=853894, encodeId=7268853894f0, content=审稿速度:4.0<br>经验分享:请问这个杂志有decision in process状态吗?我的被主编和另外一个编辑审核后,就出现了这个状态decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Sun Sep 22 10:33:39 CST 2019, time=2019-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118688, encodeId=13a5211868828, content=请问大家有没有经历过返修后出现reviewer invited的情况<br>具体过程是这样:revise submitted——editor assessment——under review——reviewer invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqyvAhYhYtvZhPQbv6W9bG48UBWtJy8AMPzibXsicSDCgv1uOJypkcnCIOviczsich5xggWr8exjPcTGA/132, createdBy=f5012466353, createdName=Luleihao, createdTime=Fri Mar 10 15:56:10 CST 2023, time=2023-03-10, status=1, ipAttribution=广东省)]
    2023-01-04 ms5000001894093922 来自北京

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:中药单体;药理机制
    经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:
    * 11.08 submit
    * 11.11 改格式
    * 11.14 under editor assessment
    * 11.15 reviewer invited + under review
    * 12.15 revise
    * 12.31 revise submit + with editor
    * 01.01 under editor assessment
    * 01.03 under review
    * 01.04 accept

    20

    展开20条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2176492, encodeId=18b221e64926e, content=歇菜了,分配到国人编辑了,看看这几天是不是就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Fri Dec 22 10:48:09 CST 2023, time=2023-12-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1198237, encodeId=3db6119823e3f, content=偏重的研究方向:中药单体<br>经验分享:咨询各位老师,reviewer invited一般多久?目前已经一个月了,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7dd357230, createdName=kkrrkf, createdTime=Tue Mar 01 04:07:35 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114786, encodeId=28612114e8660, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经病学<br>经验分享:我也终于能来分享投稿过程了~在返修的过程中多次参考梅斯医学(Medsci)论坛内的相关经验,从中获益良多,深表感谢。那时候就想着,如果能发表,我就来写写自己的经历。<br>我这篇是review,可能和article不太一样。<br>2022.8.15 submit<br>2022.8.21 修改格式,当天修回。phytomedicine的编辑非常负责任,我投的时候老打不开guide for authors页面,本来这家期刊质量也很高,我又是第一次投sci,我以为肯定会被拒就索性直接提交,没想到编辑还给了一次修改格式的机会。<br>2022.9.25 major revise 编辑和三位审稿人提了很多意见,包括文章组织形式的大改,补充毒理学依据,补充文献可靠性评估等,期限20天。看到这些意见我觉得如果我是编辑,我会拒掉这篇文章(笑)。其中最大的修改是该期刊要求系统综述,但我投了篇传统综述,我真的在怀疑编辑为啥不直接拒掉我。修改的过程比较煎熬,整个国庆假期都在改。找了润色,非常感谢我导师。<br>2022.10.14 revise submit 因为觉得很可能会被拒而忐忑不安长达一个多月。<br>2022.11.19 minor revise 只有一位审稿人提了几点文字上的意见,期限15天,很快修改完成。<br>2022.11.24 revise submit 这次没有那么忐忑不安了。<br>2022.12.12 accept 感谢编辑和审稿人,一块石头算是落地。<br>2022.12.15 proof 以及Elsevier发邮件要求补充图注,并说明非OA发表。<br>2022.12.24 proof完成返回。<br>2023.1.9 publication <br>我算是很幸运的,第一次投sci比较顺利。但也存在一些波折,返修过程中我数度觉得会被拒稿,但很感谢编辑没有因格式和语言而拒绝我,感谢审稿人严格而公正的审阅,通过他们的意见,我才认识到我的初稿是多么的粗糙和漏洞百出;汲取他们的意见后,我才真正学会了怎么去组织一篇review。更是非常感谢我的导师,是他帮我推荐了这家期刊,他真是料事如神;看到编辑和审稿人都要求编辑语言,他直接问我要不要润色,防止了我的稿件再度给编辑和审稿人造成精神污染。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a938439116, createdName=ms8000000831428565, createdTime=Wed Feb 15 19:36:58 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1215883, encodeId=14be1215883d3, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体<br>经验分享:<br>2021.12.13 submit<br>2021.12.17 返回修改格式并提交<br>2021.12.22 分配稿件编号,当天under editor assessment<br>2022.02.07 under review<br>2022.02.13 under review<br>2022.03.01 required reviews completed<br>2022.03.02 revise<br>2022.03.26 返回<br>2022.03.28 under editor assessment<br>2022.04.09 reviewer invited<br>2022.04.11 under review<br>2022.04.13 required reviews completed<br>2022.04.14 required reviews completed<br>2022.04.17 accept<br>2022.04.20 proof<br>2022.04.27 出版<br>首先,非常感谢主编、编辑以及外审人~外审,包括编辑在内共3个审稿人,比较注重创新性及原始数据,补了2个小实验,提交了原始数据。杂志水平非常棒,但是审稿周期长,临近毕业真的要慎重考虑。像我等着文章毕业这种,每天快把phytomedicine的网站及梅斯的讨论区盘烂了。这四个月受尽煎熬,好在终于赶上了毕业。<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6ed5581473, createdName=奶思小仙猪, createdTime=Sat Apr 30 21:34:16 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152921, encodeId=5d56215292109, content=有人知道返修under review后又再次under editor assessment是咋回事吗?之前初审的时候review后没有这个过程。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a428573121, createdName=ms7000001625661097, createdTime=Tue Aug 15 20:00:03 CST 2023, time=2023-08-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:<br>* 11.08 submit<br>* 11.11 改格式<br>* 11.14 under editor assessment <br>* 11.15 reviewer invited + under review <br>* 12.15 revise<br>* 12.31 revise submit + with editor <br>* 01.01 under editor assessment <br>* 01.03 under review<br>* 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=853894, encodeId=7268853894f0, content=审稿速度:4.0<br>经验分享:请问这个杂志有decision in process状态吗?我的被主编和另外一个编辑审核后,就出现了这个状态decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Sun Sep 22 10:33:39 CST 2019, time=2019-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118688, encodeId=13a5211868828, content=请问大家有没有经历过返修后出现reviewer invited的情况<br>具体过程是这样:revise submitted——editor assessment——under review——reviewer invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqyvAhYhYtvZhPQbv6W9bG48UBWtJy8AMPzibXsicSDCgv1uOJypkcnCIOviczsich5xggWr8exjPcTGA/132, createdBy=f5012466353, createdName=Luleihao, createdTime=Fri Mar 10 15:56:10 CST 2023, time=2023-03-10, status=1, ipAttribution=广东省)]
    2019-09-22 ms8415407993286297

    审稿速度:4.0
    经验分享:请问这个杂志有decision in process状态吗?我的被主编和另外一个编辑审核后,就出现了这个状态decision in process

    19

    展开19条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2176492, encodeId=18b221e64926e, content=歇菜了,分配到国人编辑了,看看这几天是不是就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=39, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Fri Dec 22 10:48:09 CST 2023, time=2023-12-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1198237, encodeId=3db6119823e3f, content=偏重的研究方向:中药单体<br>经验分享:咨询各位老师,reviewer invited一般多久?目前已经一个月了,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7dd357230, createdName=kkrrkf, createdTime=Tue Mar 01 04:07:35 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114786, encodeId=28612114e8660, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经病学<br>经验分享:我也终于能来分享投稿过程了~在返修的过程中多次参考梅斯医学(Medsci)论坛内的相关经验,从中获益良多,深表感谢。那时候就想着,如果能发表,我就来写写自己的经历。<br>我这篇是review,可能和article不太一样。<br>2022.8.15 submit<br>2022.8.21 修改格式,当天修回。phytomedicine的编辑非常负责任,我投的时候老打不开guide for authors页面,本来这家期刊质量也很高,我又是第一次投sci,我以为肯定会被拒就索性直接提交,没想到编辑还给了一次修改格式的机会。<br>2022.9.25 major revise 编辑和三位审稿人提了很多意见,包括文章组织形式的大改,补充毒理学依据,补充文献可靠性评估等,期限20天。看到这些意见我觉得如果我是编辑,我会拒掉这篇文章(笑)。其中最大的修改是该期刊要求系统综述,但我投了篇传统综述,我真的在怀疑编辑为啥不直接拒掉我。修改的过程比较煎熬,整个国庆假期都在改。找了润色,非常感谢我导师。<br>2022.10.14 revise submit 因为觉得很可能会被拒而忐忑不安长达一个多月。<br>2022.11.19 minor revise 只有一位审稿人提了几点文字上的意见,期限15天,很快修改完成。<br>2022.11.24 revise submit 这次没有那么忐忑不安了。<br>2022.12.12 accept 感谢编辑和审稿人,一块石头算是落地。<br>2022.12.15 proof 以及Elsevier发邮件要求补充图注,并说明非OA发表。<br>2022.12.24 proof完成返回。<br>2023.1.9 publication <br>我算是很幸运的,第一次投sci比较顺利。但也存在一些波折,返修过程中我数度觉得会被拒稿,但很感谢编辑没有因格式和语言而拒绝我,感谢审稿人严格而公正的审阅,通过他们的意见,我才认识到我的初稿是多么的粗糙和漏洞百出;汲取他们的意见后,我才真正学会了怎么去组织一篇review。更是非常感谢我的导师,是他帮我推荐了这家期刊,他真是料事如神;看到编辑和审稿人都要求编辑语言,他直接问我要不要润色,防止了我的稿件再度给编辑和审稿人造成精神污染。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a938439116, createdName=ms8000000831428565, createdTime=Wed Feb 15 19:36:58 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1215883, encodeId=14be1215883d3, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体<br>经验分享:<br>2021.12.13 submit<br>2021.12.17 返回修改格式并提交<br>2021.12.22 分配稿件编号,当天under editor assessment<br>2022.02.07 under review<br>2022.02.13 under review<br>2022.03.01 required reviews completed<br>2022.03.02 revise<br>2022.03.26 返回<br>2022.03.28 under editor assessment<br>2022.04.09 reviewer invited<br>2022.04.11 under review<br>2022.04.13 required reviews completed<br>2022.04.14 required reviews completed<br>2022.04.17 accept<br>2022.04.20 proof<br>2022.04.27 出版<br>首先,非常感谢主编、编辑以及外审人~外审,包括编辑在内共3个审稿人,比较注重创新性及原始数据,补了2个小实验,提交了原始数据。杂志水平非常棒,但是审稿周期长,临近毕业真的要慎重考虑。像我等着文章毕业这种,每天快把phytomedicine的网站及梅斯的讨论区盘烂了。这四个月受尽煎熬,好在终于赶上了毕业。<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=661, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6ed5581473, createdName=奶思小仙猪, createdTime=Sat Apr 30 21:34:16 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152921, encodeId=5d56215292109, content=有人知道返修under review后又再次under editor assessment是咋回事吗?之前初审的时候review后没有这个过程。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a428573121, createdName=ms7000001625661097, createdTime=Tue Aug 15 20:00:03 CST 2023, time=2023-08-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:<br>* 11.08 submit<br>* 11.11 改格式<br>* 11.14 under editor assessment <br>* 11.15 reviewer invited + under review <br>* 12.15 revise<br>* 12.31 revise submit + with editor <br>* 01.01 under editor assessment <br>* 01.03 under review<br>* 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=853894, encodeId=7268853894f0, content=审稿速度:4.0<br>经验分享:请问这个杂志有decision in process状态吗?我的被主编和另外一个编辑审核后,就出现了这个状态decision in process , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Sun Sep 22 10:33:39 CST 2019, time=2019-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118688, encodeId=13a5211868828, content=请问大家有没有经历过返修后出现reviewer invited的情况<br>具体过程是这样:revise submitted——editor assessment——under review——reviewer invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqyvAhYhYtvZhPQbv6W9bG48UBWtJy8AMPzibXsicSDCgv1uOJypkcnCIOviczsich5xggWr8exjPcTGA/132, createdBy=f5012466353, createdName=Luleihao, createdTime=Fri Mar 10 15:56:10 CST 2023, time=2023-03-10, status=1, ipAttribution=广东省)]
    2023-03-10 Luleihao 来自广东省

    请问大家有没有经历过返修后出现reviewer invited的情况
    具体过程是这样:revise submitted——editor assessment——under review——reviewer invited

    19

    展开19条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分